Translation of Academic Health Innovations Goes National Foundation of the Platform for Swiss Translational and Clinical Bio-Manufacturing (TCBM)

摘要

"The road to success consists in teaming up with the right partners". Launched in September 2018, TCBM was founded by representatives of seven Swiss Universities and University Hospitals represented by five core centers in bio-manufacturing: The Basel GMP Network, the Platform for Stem Cell Research and Regenerative Medicine (SCRM) in Bern, the team in Regenerative Medicine form Fribourg, the Swiss Institute for Cell Therapies (SICT Foundation) from Geneva-Lausanne-Lugano and the Wyss Zurich. The TCBM platform supports Swiss academic bio-manufacturing facilities which enable translation of promising scientific results into clinical applications. This initiative will benefit member sites, research groups, the interaction with regulatory authorities and most importantly, the patients in terms of access to advanced and clinical grade investigational medical products. The TCBM network is further affiliated with Biotechnet Switzerland in order to promote visibility and collaboration with the private sector.